COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
Ivermectin meta
1/3 Early, Late, PrEP, PEP
Lawrie et al., Preprint (Preprint) (meta analysis)
Ivermectin reduces the risk of death from COVID-19 – a rapid review and meta-analysis in support of the recommendation of the Front Line COVID-19 Critical Care Alliance
Source   PDF   Share   Tweet
Meta analysis confirming the effectiveness of ivermectin for COVID-19, showing ivermectin treatment mortality relative risk RR 0.17 [0.18-0.35] and prophylaxis cases RR 0.12 [0.08-0.18].

Lawrie et al., 1/3/2021, preprint, 1 author.
Details of all 63 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit